These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 22724408)

  • 1. The role of platelets in athero-thrombotic events.
    Freynhofer MK; Bruno V; Wojta J; Huber K
    Curr Pharm Des; 2012; 18(33):5197-214. PubMed ID: 22724408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet turnover in atherothrombotic disease.
    Lordkipanidzé M
    Curr Pharm Des; 2012; 18(33):5328-43. PubMed ID: 22724418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK
    Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet biology and implications for antiplatelet therapy in atherothrombotic disease.
    Montalescot G
    Clin Appl Thromb Hemost; 2011 Aug; 17(4):371-80. PubMed ID: 20566574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet therapy and vascular disease: an update.
    Buch MH; Prendergast BD; Storey RF
    Ther Adv Cardiovasc Dis; 2010 Aug; 4(4):249-75. PubMed ID: 21303843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Platelets and arterial thrombosis].
    Cazenave JP; Gachet C; Lanza F; Wiesel ML
    Bull Acad Natl Med; 2003; 187(1):35-44; discussion 45-6. PubMed ID: 14556452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options.
    Fintel DJ
    Vasc Health Risk Manag; 2012; 8():77-89. PubMed ID: 22393298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 9. Protease-Activated Receptor 1 Inhibitors: Novel Antiplatelet Drugs in Prevention of Atherothrombosis.
    Al-Khafaji K; Mutyala M; Al-Khafaji N; Harper Y; Ismail I; Hakim H; Arora RR
    Am J Ther; 2017; 24(6):e730-e736. PubMed ID: 26398717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet protease-activated receptor antagonism in cardiovascular medicine.
    Wiisanen ME; Moliterno DJ
    Coron Artery Dis; 2012 Sep; 23(6):375-9. PubMed ID: 22781741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin, hemostasis, thrombosis, and coagulation.
    Keihanian F; Saeidinia A; Bagheri RK; Johnston TP; Sahebkar A
    J Cell Physiol; 2018 Jun; 233(6):4497-4511. PubMed ID: 29052850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelets and primary haemostasis.
    Clemetson KJ
    Thromb Res; 2012 Mar; 129(3):220-4. PubMed ID: 22178577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future Antithrombotic Therapies in Cardiology.
    Bäuml M; Hilgendorf I
    Hamostaseologie; 2018 Nov; 38(4):236-239. PubMed ID: 30267387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond.
    Xu XR; Zhang D; Oswald BE; Carrim N; Wang X; Hou Y; Zhang Q; Lavalle C; McKeown T; Marshall AH; Ni H
    Crit Rev Clin Lab Sci; 2016 Dec; 53(6):409-30. PubMed ID: 27282765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents.
    Natarajan A; Zaman AG; Marshall SM
    Diab Vasc Dis Res; 2008 Jun; 5(2):138-44. PubMed ID: 18537103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-platelet therapy in patients with acute coronary syndromes].
    Kopaleishvili LA; Dzhashi IM
    Georgian Med News; 2014 Nov; (236):105-10. PubMed ID: 25541837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatment.
    Ten Cate H; Guzik TJ; Eikelboom J; Spronk HMH
    Cardiovasc Res; 2021 Jul; 117(9):2030-2044. PubMed ID: 32931586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets in atherothrombosis.
    Vorchheimer DA; Becker R
    Mayo Clin Proc; 2006 Jan; 81(1):59-68. PubMed ID: 16438480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Insights Into the Regulation of Coagulation and Thrombosis.
    Li X; Sim MMS; Wood JP
    Arterioscler Thromb Vasc Biol; 2020 May; 40(5):e119-e125. PubMed ID: 32320291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet drugs in patients with enhanced platelet turnover: biomarkers versus platelet function testing.
    Freynhofer MK; Gruber SC; Grove EL; Weiss TW; Wojta J; Huber K
    Thromb Haemost; 2015 Aug; 114(3):459-68. PubMed ID: 26272640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.